Navigation Links
GlaxoSmithKline Recognizes University of Michigan's Dr. Daniel F. Hayes as the First Recipient of the Gianni Bonadonna Breast Cancer Award
Date:8/19/2007

New Award and Fellowship Supported by Multi-Year $1.3 Million Grant to the

ASCO Foundation

PHILADELPHIA, Aug. 16 /PRNewswire/ -- Daniel F. Hayes, MD, a University of Michigan oncologist and cancer researcher whose work in clinical and laboratory studies has advanced the management of breast cancer worldwide, was named today as the first winner of the annual Gianni Bonadonna Breast Cancer Award. Supported by a multi-year grant of more than $1.3 million from GlaxoSmithKline Oncology (GSK), the award will be presented by the American Society of Clinical Oncology (ASCO) and The ASCO Foundation at the Breast Cancer Symposium in San Francisco on September 7, 2007.

"GSK is honored to sponsor this award which is being presented to Dr. Daniel Hayes, a dedicated researcher who has been at the forefront of individualized breast cancer therapy," said Paolo Paoletti, MD, Senior Vice President of the Oncology Medicine Development Center at GlaxoSmithKline. "His contributions to the field of oncology have had an important impact on our knowledge about monitoring and managing the disease, and his findings have translated into real-world benefits for patients."

Dr. Hayes, who is Clinical Director of the Breast Oncology Program at the University of Michigan Comprehensive Cancer Center, is a widely recognized expert in breast cancer clinical research, particularly with new hormonal and chemotherapeutic treatments. He and his colleagues published the first reports on the CA15-3 blood test, currently used worldwide to evaluate breast cancer patients. Dr. Hayes' more recent research focuses on pharmacogenomics, and understanding the key role genes play in chemotherapy treatment.

The new award and an accompanying fellowship were created in honor of one of the giants of modern-day medical oncology, Dr. Gianni Bonadonna, of the Instituto Nazionale Tumori in Milan, Italy. Dr. Bonadonna was responsible for ground-breaking research i
'/>"/>

SOURCE GlaxoSmithKline

Copyright©2007 PR Newswire.

0

GOOD

Page: 1 2 3

Related biology technology :

1. GenTel acquires GlaxoSmithKline chip platform
2. Fermentation Cell Culture: University Style
3. Fueling our economy with the University of Wisconsin
4. CIO Leadership Series: Ed Meachen, University of Wisconsin System
5. University, business leaders convene in Wausau
6. University of South Florida expands GE Healthcare relationship
7. State and university form network for entrepreneurial outreach
8. University center offers speed boost to manufacturers
9. Building the modern public-purpose university should be UW Systems goal
10. University Research Park to add 20 incubator suites
11. University Research Park forms ties with German tech center

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/5/2009)...PRNewswire-FirstCall/ -- Cepheid (Nasdaq: CPHD ) ...ng at the following investor conferences, and invi... Credit Suisse Healthcare Conference, P... 2009 at 10 a.m. Mountain Time, N... Tuesday, 1 December, 2009 at 10.45...
(Date:11/5/2009)...Nov. 5 /PRNewswire-Asia-FirstCall/ -- BMP Sunstone...he "Company") today announced,that the Company pla... on,Monday, November 9, 2009, after the market clo... call at 5:00 pm ET on November 9, 2009,to discuss... the call by,dialing 1-888-713-4211 or 1-617-213-4...
(Date:11/4/2009)...an Anthrax Vaccine Program must be stopped. Scott... "A Call to Arms:2009 Edition" and the o...y: The Human Anthrax Vaccine Story" to inform...top secret government science turned into for-prof...o its victims. It is available for world-wide lic...
(Date:11/4/2009)... Nektar Therapeutics (Nas...for the third quarter ended September 30, 2009. ,...2009 improved to $31.0 million or $0.33 per share,...40 per share in the third quarter of 2008. ,...rating efficiencies as compared to a year ago. To...
Breaking Biology Technology:Cepheid to Webcast Upcoming Financial Presentations 2BMP Sunstone to Report Third Quarter 2009 Financial Results 2Scott Miller's 'A Call To Arms' And 'Fatal Immunity' Are Available For World-Wide Licensing 2Scott Miller's 'A Call To Arms' And 'Fatal Immunity' Are Available For World-Wide Licensing 3Scott Miller's 'A Call To Arms' And 'Fatal Immunity' Are Available For World-Wide Licensing 4Scott Miller's 'A Call To Arms' And 'Fatal Immunity' Are Available For World-Wide Licensing 5Scott Miller's 'A Call To Arms' And 'Fatal Immunity' Are Available For World-Wide Licensing 6Scott Miller's 'A Call To Arms' And 'Fatal Immunity' Are Available For World-Wide Licensing 7Nektar Therapeutics Reports Third Quarter 2009 Financial Results 2Nektar Therapeutics Reports Third Quarter 2009 Financial Results 3Nektar Therapeutics Reports Third Quarter 2009 Financial Results 4Nektar Therapeutics Reports Third Quarter 2009 Financial Results 5Nektar Therapeutics Reports Third Quarter 2009 Financial Results 6Nektar Therapeutics Reports Third Quarter 2009 Financial Results 7Nektar Therapeutics Reports Third Quarter 2009 Financial Results 8Nektar Therapeutics Reports Third Quarter 2009 Financial Results 9Nektar Therapeutics Reports Third Quarter 2009 Financial Results 10
...lif., May 8 Onyx,Pharmaceuticals, Inc. (Nasdaq: ... Bank of America Health Care Conference on Thursda...parties may access a live webcast of the,presentat...wt/page/event_calendar , It is recommended that l...ter and download any necessary software. For those...
... Calif., May 8 Beckman Coulter,Inc. (NYSE: BEC )...of,products that simplify, automate, and innovate ...ul Glyer, Beckman Coulter,s Senior Vice President,... the following,conferences:, (Logo: http://ww... Bank of America 2008 Healthcare Conference on Wed...
...., May 8 BioSpace, the world,s leading,online bio...pany, unveiled,this morning the 2008 Bio NC(TM) Ho... Carolina., (Photo: http://www.newscom.com/cgi-b...ewscom.com/cgi-bin/prnh/20080222/CLF013LOGO ), T...pharmaceutical and,medical device communities in R...
Other Biology Technology:Beckman Coulter to Present at Upcoming Healthcare Conferences 2BioSpace Launches 6th Edition of Bio NC(TM) Hotbed Campaign 2
(Date:11/4/2009)...g Beach and Riverside are responsible for a signif...and the true impact of air pollution and ship emis...d, according to researchers at the University of S...pears in an online edition of the American Journa...f all childhood asthma cases in Long Beach and six...
(Date:11/4/2009)..., hold the power to help militaries and munitions ...ic waste on test sites. , Compounds known as nit...orld War II and have been used in military munitio...ften used to propel tank shells and act like a mor...d knowledge of their environmentally harmful effec...
(Date:11/4/2009)...eived more than $10 million in research grants fro...mulus program, bringing thetotal amount of stimulu...n. Thirty-three projects achieved stimulus fundin... , "The university has thoughtfully undertaken a... excellence to federal agency priorities. Through...
Breaking Biology News(10 mins):USC study finds big air pollution impacts on local communities 2Genomic research will enable greener cleanup of military explosive test sites 2OU achieves $10 million in stimulus grants for 33 projects on the Norman campus 2OU achieves $10 million in stimulus grants for 33 projects on the Norman campus 3Viral Genetics Scientist Presents Potential New Treatment for Drug Resistant Brain Tumors at Aspen Symposium 13511 1Viral Genetics Scientist Presents Potential New Treatment for Drug Resistant Brain Tumors at Aspen Symposium 13511 2Viral Genetics Scientist Presents Potential New Treatment for Drug Resistant Brain Tumors at Aspen Symposium 13511 3VIVUS Reports Second Quarter 2009 Financial Results 54258 1VIVUS Reports Second Quarter 2009 Financial Results 54258 2VIVUS Reports Second Quarter 2009 Financial Results 54258 3VIVUS Reports Second Quarter 2009 Financial Results 54258 4VIVUS Reports Second Quarter 2009 Financial Results 54258 5VIVUS Reports Second Quarter 2009 Financial Results 54258 6VIVUS Reports Second Quarter 2009 Financial Results 54258 7Ohio Judge Rules Tobacco Settlement Funds Should Be Used as Intended to Reduce Tobacco Use and Save Lives 54255 1Ohio Judge Rules Tobacco Settlement Funds Should Be Used as Intended to Reduce Tobacco Use and Save Lives 54255 2
... The next time you mutter about the high cost of r...hat microbes share your pain. In the first study ...ping Xu, associate professor of biology at McMaste...hological and behavioural stress on microbes. His ...netics, published by the Genetics Society of Ameri...
... Some HIV medications lead to the development of d... percent of their medications. For other medicatio... of their pills. These differences appear to be ex... of the drug-resistant HIV, say AIDS researchers i...erg, MD, MPH, an AIDS specialist at the University...
... A more accurate method for measuring blood levels...tream and repair damage to the arterial lining has... cardiologists. These cells, known as endothelial ...arrow and travel to the site of arterial damage. ,... used to assess a patient,s degree of coronary art...
Other Biology News:Sex: It's costly but worth it. Just ask a microbe 2Viral 'fitness' explains different resistance patterns to aids drugs 2Measuring artery repair cells could become new heart disease test 2Measuring artery repair cells could become new heart disease test 3
Rabbit Anti-ATF4, phospho (Ser245) Polyclonal Antibody, Unconjugated from Abcam
Rabbit Anti-Human MMP-25 (Membrane-type MMP-6, Mt6MMP), hinge region, Antibody, Unconjugated from CEDARLANE Laboratories Limited
Mouse Anti-nicotinic Acetylcholine Receptor Monoclonal Antibody, Unconjugated, Clone 88B from Abcam
Rabbit Anti-MAL Polyclonal Antibody, Unconjugated from Abcam
Biology Products: